![Redefining beta-blocker use in hypertension: selecting the right beta- blocker and the right patient - ScienceDirect Redefining beta-blocker use in hypertension: selecting the right beta- blocker and the right patient - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1933171116305915-gr1.jpg)
Redefining beta-blocker use in hypertension: selecting the right beta- blocker and the right patient - ScienceDirect
![Beta-blockers in noncardiac surgery: Did observational studies put us back on safe ground? - British Journal of Anaesthesia Beta-blockers in noncardiac surgery: Did observational studies put us back on safe ground? - British Journal of Anaesthesia](https://www.bjanaesthesia.org.uk/cms/attachment/ecc4953f-f3fe-4e69-91fe-08a858def2be/gr1_lrg.jpg)
Beta-blockers in noncardiac surgery: Did observational studies put us back on safe ground? - British Journal of Anaesthesia
![Clinical Events After Discontinuation of β‐Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction | Circulation: Cardiovascular Quality and Outcomes Clinical Events After Discontinuation of β‐Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction | Circulation: Cardiovascular Quality and Outcomes](https://www.ahajournals.org/cms/asset/2562175d-f6c0-47f0-a9eb-762fcdad54a6/e004356fig01.gif)
Clinical Events After Discontinuation of β‐Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction | Circulation: Cardiovascular Quality and Outcomes
![Beta-blockers and Short-Term Cardiovascular Outcomes In Patients Hospitalized For Acute Coronary Syndrome and a Left Ventricular Ejection Fraction ≥40% | Scientific Reports Beta-blockers and Short-Term Cardiovascular Outcomes In Patients Hospitalized For Acute Coronary Syndrome and a Left Ventricular Ejection Fraction ≥40% | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-60528-y/MediaObjects/41598_2020_60528_Fig1_HTML.png)
Beta-blockers and Short-Term Cardiovascular Outcomes In Patients Hospitalized For Acute Coronary Syndrome and a Left Ventricular Ejection Fraction ≥40% | Scientific Reports
![Frontiers | Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial Frontiers | Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial](https://www.frontiersin.org/files/Articles/619088/fphar-12-619088-HTML-r1/image_m/fphar-12-619088-g001.jpg)
Frontiers | Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial
تعلم اونلاين - 🔥 Beta-blockers should not be withdrawn #abruptly, as rebound effects may precipitate dangerous #arrhythmias, worsening angina or #MI | Facebook
![DoktorWeigl erklärt Metoprolol Wirkstoff – Wirkung, Dosierung und Risiken eines wichtigen Betablocker DoktorWeigl erklärt Metoprolol Wirkstoff – Wirkung, Dosierung und Risiken eines wichtigen Betablocker](https://www.doktorweigl.de/wp-content/uploads/2018/11/Metoprolol_Metoprolol-Wirkstoff_Metoprolol-Betablocker-1.jpg)